US authorization of first COVID vaccine marks new phase in safety monitoring

Heidi Ledford

Nature, 2020, vol. 588, issue 7838, 377-378

Abstract: The FDA has issued an emergency-use authorization for the Pfizer–BioNTech vaccine. Regulators are gearing up to look for side effects.

Keywords: Medical research; Vaccines; SARS-CoV-2; Infection (search for similar items in EconPapers)
Date: 2020
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.nature.com/articles/d41586-020-03542-4 Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:588:y:2020:i:7838:d:10.1038_d41586-020-03542-4

Ordering information: This journal article can be ordered from
https://www.nature.com/

DOI: 10.1038/d41586-020-03542-4

Nature is currently edited by Magdalena Skipper

More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().